Stocksigma LogoStocksigma Logo

Alivus Life Sciences Signs Shareholders' Agreement to Acquire Stake in IQGEN-X Pharma

Alivus Life Sciences Limited executed a Shareholders' Agreement with IQGEN-X Pharma Private Limited and its continuing existing shareholders (Dr

Alivus Life Sciences Signs Shareholders' Agreement to Acquire Stake in IQGEN-X Pharma

Alivus Life Sciences Ltd 路 Others (Uncategorized) 路 11 Nov 2026, 10:22 pm

Alivus Life Sciences Signs Shareholders' Agreement to Acquire Stake in IQGEN-X Pharma Alivus Life Sciences Limited executed a Shareholders' Agreement with IQGEN-X Pharma Private Limited and its continuing existing shareholders (Dr. Mandar Kodgule and Dr. Yogita Kodgule), following a share purchase agreement to acquire a 76% stake in IQGEN-X. Alivus holds an option to purchase the remaining 24% stake after 5 years from transaction closing at a pre-agreed benchmark price. The agreement grants Alivus majority board representation (2 out of 3 directors) without impacting the management or control of the listed entity.

Original exchange filing (PDF)

More announcements from Alivus Life Sciences Ltd

All Alivus Life Sciences Ltd announcements